Assuming study is required, the following results were found.

  • Pediatric onset multiple sclerosis study examines baffling, often-overlooked disease

    P. Cross, a senior research specialist in social work at the University of Illinois. Cross is also a co-author of a recent study on families of children with pediatric onset MS, published in the Journal of Child and Adolescent Trauma. "Many of these...

    https://mschristian.org/index.php/blog/pediatric-onset-multiple-sclerosis-study-examines-baffling-often-overlooked-disease
  • Tecfidera (dimethyl fumarate)

    not clear if Tecfidera is the cause of weight gain or loss. Fatigue People who take Tecfidera can experience fatigue. In one study, fatigue happened in 17 percent of people who took it. This side effect may decrease or go away with continued use of the...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • Researchers Identify Nerve Cells That Are Vulnerable to Damage in MS

    disease progression and cognitive impairment).They also confirmed the role of immune B cells in this type of damage.This study yields important new information about how MS may progress and why certain symptoms worsen. If confirmed, it is likely to...

    https://mschristian.org/index.php/blog/researchers-identify-nerve-cells-that-are-vulnerable-to-damage-in-ms
  • Research explains why many psychiatric drugs that work in the lab don’t work in people

    that could explain why many psychiatric drugs that work in the lab don’t work in people. Now an incredibly detailed new study shows it is also because of hundreds of crucial differences in gene expression between mouse and human brains. In other words,...

    https://mschristian.org/index.php/blog/research-explains-why-many-psychiatric-drugs-that-work-in-the-lab-don-t-work-in-people
  • Vegetable-rich diet lowers fatigue in multiple sclerosis patients by raising good cholesterol

    -- or good cholesterol -- may improve fatigue in multiple sclerosis patients, according to a new University at Buffalo-led study. The pilot study, which investigated the effects of fat levels in blood on fatigue caused by multiple sclerosis, found that...

    https://mschristian.org/index.php/blog/vegetable-rich-diet-lowers-fatigue-in-multiple-sclerosis-patients-by-raising-good-cholesterol
  • New clues to the origin and progression of multiple sclerosis

    electric signals and causes the symptoms of the disease. While it is unknown why the immune system attacks the myelin, a study by researchers at Karolinska Institutet shows that the cells that produce myelin, oligodendrocytes, might play an unexpected...

    https://mschristian.org/index.php/blog/new-clues-to-the-origin-and-progression-of-multiple-sclerosis
  • MS Risk Nearly Doubles 15 Years Following Teen Concussion - Medscape

    for multiple sclerosis (MS) later in life, especially 15 years or more following their head trauma, a large retrospective study suggests. This risk for developing MS over time nearly doubled in this population compared with people without a history of...

    https://mschristian.org/index.php/blog/ms-risk-nearly-doubles-15-years-following-teen-concussion-medscape
  • MS Patients Should Be Informed about Pregnancy Risks and Family Planning, Experts Say

    to the false belief that pregnancy would worsen their disease course. A shift in knowledge occurred in 1998 when the PRIMS study (Pregnancy in Multiple Sclerosis multicenter European study) showed that, overall, pregnancy did not affect the long-term...

    https://mschristian.org/index.php/blog/ms-patients-should-be-informed-about-pregnancy-risks-and-family-planning-experts-say
  • MS: High-strength MRI may predict disease progression

    Researchers were able to detect previously unidentified MS lesions in the brain using a powerful MRI scanner. Their study reveals that the development of lesions in the brain's cortical gray matter may be a predictor of neurological disability for...

    https://mschristian.org/index.php/blog/ms-high-strength-mri-may-predict-disease-progression-1
  • Prozac and Autism in Children

    and colleagues, in JAMA. The adjusted analysis should be given more weight because it corrects for imbalances in the study, Reddihough maintained. "While this is a study with negative findings, it is an important addition to the evidence base for...

    https://mschristian.org/index.php/blog/prozac-and-autism-in-children
  • Study finds that many people diagnosed with MS do not have the condition

    in walking. MS and migraine attacks also have some symptoms in common, including dizziness and vision impairment. A recent study pooled data on people who had received a wrong diagnosis of MS and found that 72 of the 110 patients had other conditions,...

    https://mschristian.org/index.php/blog/study-finds-that-many-people-diagnosed-with-ms-do-not-have-the-condition-1
  • MS Patients Have Low Blood Levels of Infection-fighting Antibodies, Study Finds - Multiple Sclerosis News Today

    antibodies that can protect against infection, regardless of whether they are using a disease-targeted therapy or not, a study reports. These levels were not so low as to risk infection on their own, but were lower-than-normal across all MS subtypes and...

    https://mschristian.org/index.php/blog/ms-patients-have-low-blood-levels-of-infection-fighting-antibodies-study-finds-multiple-sclerosis-news-today
  • Researchers optimize aptamer with enhanced myelin-binding properties for MS treatment

    Date:Source:Mary Ann Liebert, Inc./Genetic Engineering NewsSummary:A new study has demonstrated the enhanced ability of an optimized 20-nucleotide derivative of a larger DNA aptamer to bind myelin in a mouse model of multiple sclerosis. FULL STORY -A...

    https://mschristian.org/index.php/blog/researchers-optimize-aptamer-with-enhanced-myelin-binding-properties-for-ms-treatment
  • Aubagio (teriflunomide)

    how effective Aubagio is: In one clinical trial, about 72% of people who took Aubagio stayed free of relapses during the study. This was compared to 62% of people who took a placebo. Two clinical studies looked at people with relapsing MS. In one study,...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • MS genes formerly missing-in-action have been found

    many more people," said Yale's Chris Cotsapas, associate professor of neurology and genetics and corresponding author of the study. "These variants explain an extra 5% of risk." Previous theories have held that combinations of common variants act in...

    https://mschristian.org/index.php/blog/ms-genes-formerly-missing-in-action-have-been-found
  • How childhood viral infections may later drive multiple sclerosis

    may prime it for the development of autoimmune conditions, such as multiple sclerosis, later in life — this is what a recent study that scientists conducted in mice seems to suggest. Could viral infections that occur during childhood 'pave the way' for...

    https://mschristian.org/index.php/blog/how-childhood-viral-infections-may-later-drive-multiple-sclerosis
  • Siponimod Delays Time to Wheelchair in Secondary Progressive MS - Neurology Times

    A new analysis of the EXPAND study population has suggested that siponimod (Mayzent, Novartis) may have an additional long-term benefit for patients with secondary progressive multiple sclerosis (MS) beyond the study’s core findings. The oral selective...

    https://mschristian.org/index.php/blog/siponimod-delays-time-to-wheelchair-in-secondary-progressive-ms-neurology-times
  • Can Anti-TNF Drugs Reduce Alzheimer's Risk?

    she told MedPage Today. The findings also reinforce the concept that late-onset Alzheimer's may have multiple causes, added study author Mark Gurney, PhD, chief executive officer of Tetra Therapeutics in Grand Rapids, Michigan. "In this subset of...

    https://mschristian.org/index.php/blog/can-anti-tnf-drugs-reduce-alzheimer-s-risk
  • Blue Cross Blue Shield Association Reports Americans with Multiple Sclerosis are Three Times More Likely to Have Behavioral Health Conditions - BioSpace

    to 2017. The findings revealed that the average age of someone living with MS is 47 years old. Additional findings from the study are: There were 21,700 new MS diagnoses – a 4 percent increase from 2014 to 2017.75 percent of those diagnosed with MS are...

    https://mschristian.org/index.php/blog/blue-cross-blue-shield-association-reports-americans-with-multiple-sclerosis-are-three-times-more-likely-to-have-behavioral-health-conditions-biospace
  • Small Study Finds that a Diet that Improves Cholesterol Levels May Reduce MS-Related Fatigue

    August 16, 2019 SUMMARY In a small pilot study, researchers found that a specific diet that improved participants’ lipid profile (levels of blood fats, including cholesterol and triglycerides) and reduced body weight also led to reductions in...

    https://mschristian.org/index.php/blog/small-study-finds-that-a-diet-that-improves-cholesterol-levels-may-reduce-ms-related-fatigue

Results 21 - 40 of 147
 
 

Follow Us on Twitter

Follow Us On Twitter - Image